Together, these actions help keep blood sugar steady and reduce overeating
After reviewing studies and patient data, researchers found that people with Type 2 diabetes taking semaglutide may have about twice the risk of developing NAION compared to those not taking the drug
[3] Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A
This new version, called Wegovy HD, will have a dosage of 7.2 milligrams, administered weekly by injection
SGLT2 Inhibitors There are several cardiovascular outcome trials testing the efficacy of SGLT2-i as listed in Table 3 and Table 4
Some patients will do best with injections, some with oral therapies, and some may transition between approaches over time," Hatipoglu said